BioMerieux rises after FY results

Biomerieux SA

07/03/2025 08:22

** Shares in France's BioMerieux BIOX.PA jump 2% after positive full-year sales and profit at the in-vitro diagnostics firm, two traders say

** The company reported on Friday a 10.3% annual growth in its annual revenues, to 3.98 billion euros ($4.31 billion), recurring operating income up 20% at constant rates and scope to 673 million euros

** It forecast 2025 growth in profit from recurring operations by at least 10%

** BioMerieux's results fully validate its growth drivers and potential for operational leverage, Midcap Partners says, adding it will review the group's 2025 estimates and TP with positive, and confirming its "buy" rating

** Including Friday's rise, the stock has gained 13% YTD​

($1 = 0.9228 euros)

 (Reporting by Alessandro Parodi)

 ((alessandro.parodi@thomsonreuters.com))